HIV vaccine (Celldex Therapeutics/Rockefeller University)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameHIV vaccine (Celldex Therapeutics/Rockefeller University)

Drug Alias NameCDX-2401DCVax-001

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCelldex Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe Rockefeller University

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A